Anthocyans (anthocyanins and their aglycones anthocyanidins) are colorful pigments, naturally occurring in fruits. They exhibit many biological effects and have potent health benefits. Anthocyans are widely used as dietary supplements and the safety of products containing them is of great importance. To investigate whether anthocyans influence the expression of hepatic uptake transporters from the organic anion transporting polypeptide (SLCO gene/OATP protein) family, we carried out studies on primary cultures of human hepatocytes. The hepato-cellular accumulation of widely used drugs such as statins and some anticancer drugs is mediated by the liver-specific OATP1B1 and OATP1B3, thus any interference with expression of these particular transporters might influence therapeutic outcomes. We evaluated the effects of 21 anthocyanins and their corresponding 6 anthocyanidins on the expression levels of SLCO1B1/SLCO1B3 by RT-qPCR.
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Introduction
Anthocyans are a sub-group of flavonoids that exist in all tissues of higher plants as water-soluble pigments, responsible for the red, blue or purple colors of berries, grapes, apples, corn and many vegetables. 1 The broad term "anthocyan" encompasses both glycosides (termed anthocyanins) and aglycones (termed anthocyanidins). In higher plants, only anthocyanins are found, and in these, the pigment is linked to one or more sugars, often glucose, galactose, arabinose and xylose, but also to rather rare sugars including rhamnose, sophoroside or sambubioside. 2 The most common anthocyanidins are cyanidin, delphinidin, malvidin, pelargonidin, peonidin, and petunidin. 1 Many studies have demonstrated that anthocyans exhibit anti-proliferative, anti-apoptotic, anti-tumor, antimutagenic, anti-oxidant, anti-inflammatory and nitric oxide inhibitory effects in vitro that may be linked to their ability to confer important health benefits. Furthermore they are reported to reduce the incidence of diabetes, cardiovascular disease, arthritis and cancer.
1, [3] [4] [5] [6] For the last years, public interest in the cancer chemopreventive properties of dietary constituents has increased as people have sought effective and safe diet-derived alternatives to pharmaceuticals. 7 In a study, the daily intake of anthocyanins in individuals in the U.S. has been estimated to be approximately 180-215 mg/day. 8 Anthocyan-containing dietary supplements are available as juices, dried juice, dried fruits or water extracts, and are claimed to offer such an alternative. 9 Importantly, the dose of anthocyans in certain dietary supplements is extraordinarily high, e.g. in over-the counter drugs taken for the treatment against diarrhea (blueberry extracts, daily doses of 100-200 mg anthocyans) or against urinary tract infections (cranberry extracts, 60-225 mg per dose). However, there are no clinical studies investigating their effectiveness or potential side effects due to interactions with drug transport. For a critical review of the literature on anthocyans in dietary supplements see Espin et al., 2007. 10 Anthocyans are effectively absorbed in the intestine and are transported into the liver, where they are metabolized and excreted into bile. 3, 11, 12 Therefore, it is of special interest to us to discover how these compounds may interact with the transport proteins that mediate the uptake of endogenous and exogenous compounds into hepatocytes. Two proteins, OATP1B1 and OATP1B3, members of the SLC superfamily of uptake transporters (SLC family 21) play an important role in the hepatic uptake of bilirubin, bile acids, conjugated steroids, eicosanoids and thyroid hormones, as well as xenobiotics, phytochemicals and drugs. There is considerable substrate overlap between these two
OATPs, and if their substrates are co-administered, they may interfere with their transport capacity.
OATP1B1 and OATP1B3 are expressed almost exclusively in hepatocytes and pharmacokinetic consequences are expected for the hepatobiliary elimination of drugs that are preferentially taken up by either OATP1B1 and/or OATP1B3, e.g. chemotherapeutic drugs such as methotrexate, paclitaxel and statins like atorvastatin. [13] [14] [15] This is especially important for drugs with a narrow therapeutic index, such as cytostatics and statins, for which high concentrations in blood plasma can result in severe toxic side effects and in case of statins in severe myopathy. 16, 17 In addition to the consequences of altered substrate competition, altered levels of expression of these OATPs will also change the intracellular concentration and the efficacy of these therapeutics. In this study, we focused on the effects of the anthocyans on these two "liver-specific" OATPs with a unique substrate specificity, although other OATPs, e.g. OATP2B1
are also highly expressed in liver. 18 It has been suggested that the expression of SLCO1B1 and SLCO1B3 genes and the corresponding proteins can be modified by drugs, xenobiotics and natural compounds. 19 Studies in rodents showed that activation of nuclear receptors, such as the pregnane X receptors (PXR) by natural compounds, for example the polyphenol hyperforin, and synthetic drugs such as the antibiotic rifampicin modulate the expression of these transporters. 20 However, a recent study using human hepatocytes revealed that rifampicin, although an effective stimulator of PXR, has little effect on SLCO1B1 and SLCO1B3 expression. Cultures were maintained at 37°C and 5% CO 2 in a humidified incubator. All hepatocytes were treated in a serum-free medium for 24 h with the tested compounds and/or vehicle (DMSO; 0.1% v/v). 3, 22 No toxicity was found using these conditions in human hepatocytes even at the high concentration of 50 µM using trypan blue exclusion and the MTT-test for toxicity measurements. 
Materials and methods
Chemicals
Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)
Total RNA was isolated using TRI Reagent® and cDNA was synthesized according to the common protocol, using M-MLV Reverse Transcriptase F-572 (Finnzymes, Thermo Scientific, Portsmouth, NH, USA) and random hexamers 3801 (Takara, Saint-Germain-en-Laye, France). 23 TaqMan® Gene
Expression Assays (Applied Biosystems, Foster City, CA, USA) were purchased for SLCO1B1 and SLCO1B3 (containing intron-spanning primers: SLCO1B1: Hs00272374_m1, SLCO1B3:
Hs00251986_m1). To select appropriate reference genes, the expression levels of 12 different human housekeeping mRNAs were analyzed using a geNorm reference gene selection kit with PerfectProbeTM (PrimerDesign Ltd., Southampton, UK). GAPDH (glyceraldehyde-3 phosphate dehydrogenase), YWHAZ (14-3-3 protein zeta/delta) and TOP1 (DNA topoisomerase 1) were selected as acceptable reference genes for TaqMan® q-PCR analysis of the samples as previously described. 23 Data were analyzed by the delta-delta Ct method. Results are expressed as foldinduction over DMSO-treated cells. Data were visualized as a heat map using Java TreeView.
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Western blotting
Total protein extracts were prepared as described elsewhere. 25 After SDS-PAGE separation and
Western blot transfer, filters were probed with rabbit polyclonal antisera against OATP1B1 (rabbit polyclonal; LS-C161285; LifeSpan BioSciences, Seattle, WA, USA) or OATP1B3 (rabbit polyclonal; LS-C159033; LifeSpan BioSciences) giving immunoreactive bands at approx.. 70 and 90 kDa, respectively. Chemiluminescent detection was performed using a horseradish peroxidaseconjugated secondary antibody and an ECL detection kit both from Thermo Scientific (Portsmouth, NH, USA). A VersaDoc 4000MP Imaging System (Bio-Rad Laboratories Inc., California, US) was used to capture images. As a loading control, the blots were probed to detect β-actin (band at 42kDa) using an anti-beta actin antibody from Abcam (Oxford, G.B). Densitometric analysis of immunoblots was done by VersaDoc 4000MP Imaging System.
Statistics
Data are given either as means ± SD or as means (min-max values) as indicated in the legends to 
Results
To assess the effects of anthocyans on the expression of liver-specific SLCO1B1/OATP1B1 and SLCO1B3/OATP1B3 in a system that reflects the situation in patients, we used primary hepatocytes from different multi-organ donors for the investigations. 26, 27 Previous studies showed that expression of these OATPs is greatly reduced in liver cancer cell lines and different mechanisms regulating their expression differ between hepatocytes and human liver cell lines.
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Effects of anthocyanidins on OATP expression
Initially, we elucidated the effect of the aglycones, namely the anthocyanidins cyanidin, peonidin, petunidin, pelargonidin, delphinidin, and malvidin on SLCO1B1 and SLCO1B3 expression levels in LH45, LH46, and LH47 cells. For comparison, we also used long-term preserved HEP220670 (HEP) cells derived from one donor. Cells were incubated for 24h with anthocyanidins (50 µM), and the vehicle (DMSO, 0.1% v/v), before mRNA and protein were isolated and SLCO/OATP1B1 and SLCO/OATP1B3 levels were determined.
As shown in Table 2 , treatment with pelargonidin reduced SLCO1B3 gene levels by approximately 25%. In HEP cells, no significant alterations in the mRNA expression levels were seen with any anthocyanidin.
Effects of anthocyanins on OATP expression
In the next series of experiments, the effects of 21 anthocyanins (50 µM) were tested on four The mean values and minimum and maximum values for SLCO1B1 and SLCO1B3 levels in the LH cells are summarized in Table 3 . The data indicate that the effects of anthocyanins on SLCO1B1 expression are rather moderate, revealing a maximal induction of 1.6-fold (mean values) of SLCO1B1 with malvidin-3-O-galactoside chloride. A small, but significant increase in the mean levels of SLCO1B1 was also produced by two other anthocyanins: malvin chloride (1.51-fold) and cyanidin-3-O-sophoroside chloride (1.38-fold).
Protein levels corresponded with the mRNA response pattern in hepatocyte samples. Higher levels of immunoreactive OATP1B1 after malvidin chloride and malvidin-3-O-galactoside chloride treatment reflected the higher mRNA levels. Incubation with pelargonin chloride and pelargonidin-3-Orutinoside chloride, which had no effect on the SLCO1B1 gene, also did not alter OATP1B1 protein levels ( Fig. 3 and Table 4 ).
In contrast to SLCO1B1/OATP1B1, mean SLCO1B3 expression in LH45, LH46, LH47 and LH49 cells was not significantly increased by anthocyanins (Table 3) . Notably, SLCO1B3 expression was reduced by nearly 20% (mean value 0.817-fold) after delphin chloride incubation. Again, OATP1B3
protein levels corresponded with the mRNA levels ( Fig. 3 and Table 4 ).
In control experiments in the hepatocytes, we also noticed that rifampicin does not induce the expression of either SLCO1B3 or SLCO1B3 (n-fold induction 0.74-0.99). This is not surprising, as in a previous study, rifampicin derivatives, known to be common inducers of some drug metabolising P450 enzymes (CYPs) and transporters 20, 21, 29 , did also not show any specific upregulation of SLCO1B1/SLCO1B3 genes.
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Discussion
Our investigation into the effects of 27 anthocyans on the expression of SLCO/OATP1B1 and SLCO/OATP1B3 in primary human hepatocytes revealed that these phytochemicals can indeed influence the expression of these liver-specific transporters. Interestingly, we observed induction of SLCO/OATP1B1 expression, but reduction of SLCO/OATP1B3 expression with some anthocyans.
Because the expression levels of liver-specific OATP1B1 and OATP1B3 is generally reduced in hepatocellular cancer cell lines such as HepG2 27 we studied the effects of anthocyans on transporters expression in a system that reflects the situation in patients by using primary hepatocytes from different multi-organ donors.
In all hepatocyte cell samples tested, increases of SLCO/OATP1B1 levels of at least 10% occurred in response to the anthocyanins malvin chloride, malvidin-3-O-galactoside chloride, and cyanidin-3-Osophoroside chloride. For SLCO/OATP1B3, a reduction in the expression levels was seen with one anthocyanidin, pelargonidin, and one anthocyanin, delphin chloride (Table 2 and substrates in patients cannot be excluded if the liver function is impaired. For example during cholestasis or hepatic inflammation, the polarity of hepatocytes is no longer maintained and the permeability between blood and bile is changed. 30 These processes lead to an accumulation of compounds in the liver with the risk of further interactions between dietary compounds and drugs on the transporter level. These might be even more important if patients take preparations with a better bioavailability as dietary supplements. Such conclusions were also drawn from data showing the effects of silymarin from milk thistle preparations on hepatic uptake transporters. 31 The transporters OATP1B1 and OATP1B3 mediate the intracellular accumulation of widely used drugs such as statins and chemotherapeutic agents, so our findings are important because altered expression of OATP1B1 and OATP1B3 by these dietary constituents might change the efficacy of a drug therapy. However, it must be considered that the SLCO/OATP expression pattern varies considerably between hepatocytes from individual donors 27 and those variations may have a more severe impact on the OATP-mediated cellular accumulation of drugs in patients. It is also important that in the liver, OATP1B1 is expressed in all hepatocytes throughout the lobules, whereas OATP1B3 expression is highest in hepatocytes located around the central vein. 32 This implicates that their expression in liver is regulated differently, which could also account for the different reaction of these SLCOs/OATPs to anthocyans.
In general, our data concur with previous studies on the effect of anthocyans on biotransformation pathways that showed only small effects of anthocyans on selected enzymes. Kamenickova et al. Tables   Table 1 Chemical structures of anthocyans B: ß-actin in LH45, LH46, LH47, LH49 at 42 kDa was used as a loading control.
C: Immunoreactive OATP1B3 in delphin chloride-treated LH samples
